Amyloid β-mediated oxidative and metabolic stress in rat cortical neurons: No direct evidence for a role for H2O2 generation

Journal of Neurochemistry

Volumn 67, Issue 4, 1996, Pages 1595-1606

  Zhang, Zhiyuan ^a   Rydel, Russell E ^b   Drzewiecki, Gary J ^a   Fuson, Kimberly ^a   Wright, Sarah ^b   Wogulis, Mark ^b   Audia, James E ^a   May, Patrick C ^a   Hyslop, Paul A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Athena Neurosciences Inc   (United States)

Author keywords

Alzheimer's disease; Amyloid ; ATP; Cortical neurons; Oxidative injury

Indexed keywords

AMYLOID BETA PROTEIN; HYDROGEN PEROXIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN METABOLISM; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0029809656     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67041595.x     Document Type: Article

References (49)

1. Arispe N., Pollard H. B., and Rojas E. (1993a) Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA 90, 10573-10577.
2. Arispe N., Rojas E., and Pollard H. B. (1993b) Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90, 567-571.
3. Behl C., Davis J., Cole G. M., and Schubert D. (1992) Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-950.
4. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817-827.
5. Benzi G. and Moretti A. (1995) Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radic. Biol. Med. 19, 77-101.
6. Beutler E. (1984) Red Cell Metabolism: A Manual of Biochemical Methods. Grune and Stratton, Orlando, Florida.
7. Brodie A. and Reed D. J. (1987) Reversible oxidation of glyceraldehyde-3-phosphate dehydrogenase thiols in human lung carcinoma cells by hydrogen peroxide. Biochem. Biophys. Res. Commun. 148, 120.
8. Carter W. O., Narayanan P. K., and Robinson J. P. (1994) Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J. Leukoc. Biol. 55, 253-258.
9. Chance B., Sies H., and Boveris A. (1979) Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527-605.
10. Clemens J. A., Saunders R. D., Ho P. P., Phebus L. A., and Panetta J. A. (1993) The antioxidant LY231617 reduces global ischemic neuronal injury in rats. Stroke 24, 716-723.
11. Cotman C. W. and Pike C. J. (1994) β-Amyloid and its contributions to neurodegeneration in Alzheimer's disease, in Alzheimer Disease (Terry R. D., Katzman R., and Bick K. L., eds), pp. 305-315. Raven Press, New York.
12. Davies P. (1994) Neuronal abnormalities, not amyloid, are the cause of dementia in Alzheimer's disease, in Alzheimer Disease (Terry R. D., Katzman R., and Bick K. L., eds), pp. 327-333. Raven Press, New York.
13. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., et al. (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein [see comments]. Nature 373, 523-527.
14. Goodman Y., Steiner M. R., Steiner S. M., and Mattson M. P. (1994) Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 654, 171-176.
15. Harris M. E., Hensley K., Butterfield D. A., Leedle R. A., and Carney J. M. (1995) Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131, 193-202.
16. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Floyd R. A., and Butterfield D. A. (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA 91, 3270-3274.
17. Hensley K., Aksenova M., Carney J. M., Harris M., and Butterfield D. A. (1995a) Amyloid beta-peptide spin trapping. I: Peptide enzyme toxicity is related to free radical spin trap reactivity. Neuroreport 6, 489-492.
18. Hensley K., Aksenova M., Carney J. M., Harris M., and Butterfield D. A. (1995b) Amyloid beta-peptide spin trapping. II: Evidence for decomposition of the PBN spin adduct. Neuroreport 6, 493-496.
19. Higgins L. S., Catalane R., Quon D., and Cordell B. (1993) Transgenic mice expressing human beta-APP751, but not mice expressing beta-APP695, display early Alzheimer's disease-like histopathology. Ann. NY Acad. Sci. 695, 224-227.
20. Horn J. T., Estridge T., Pechous P., and Hyslop P. A. (1995) The amyloidogenic peptide human amylin augments the inflammatory activities of eosinophils. J. Leukoc. Biol. 58, 526-532.
21. Hyslop P. A., Hinshaw D. B., Halsey W. Jr., Schraufstatter I. U., Sauerheber R. D., Spragg R. G., Jackson J. H., and Cochrane C. G. (1988) Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J. Biol. Chem. 263, 1665-1675.
22. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., and Muller-Hill B. (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736.
23. Klegeris A., Walker D. G., and McGeer P. L. (1994) Activation of macrophages by Alzheimer beta amyloid peptide. Biochem. Biophys. Res. Commun. 199, 984-991.
24. LeBel C. P., Ischiropoulos H., and Bondy S. C. (1992) Evaluation of the probe 2′,7′-dichlorofluorescein as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5, 227-231.
25. Little C. and O'Brien P. J. (1969) Mechanism of peroxide-inactivation of the sulphydryl enzyme glyceraldehyde-3-phosphate dehydrogenase. Eur. J. Biochem. 10, 533-538.
26. Lockhart B. P., Benicourt C., Junien J.-L., and Privat A. (1994) Inhibitors of free radical formation fail to attenuate direct β-amyloid 25-35 peptide-mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39, 494-505.
27. Lorenzo A. and Yankner B. A. (1994) β-Amyloid neurotoxicity requires filbril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247.
28. Martins R. N., Harper C. G., Stokes G. B., and Masters C. L. (1986) Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J. Neurochem. 46, 1042-1045.
29. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. E. (1992) Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
30. Mattson M. P., Tomaselli K. J., and Rydel R. E. (1993) Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res. 621, 35-49.
31. May P. C., Gitter B. D., Waters D. C., Simmons L. K., Becker G. W., Small J. S., and Robison P. M. (1992) Beta-amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol. Aging 13, 605-607.
32. May P. C., Boggs L. N., and Fuson K. S. (1993) Neurotoxicity of human amylin in rat primary hippocampal cultures: similarity to Alzheimer's disease amyloid-β neurotoxicity. J. Neurochem. 61, 2330-2333.
33. Mecocci P., MacGarvey M. S., and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
34. 2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. Am. J. Physiol. 268, C227-C236.
35. Oded B.-Y., Boxer P. A., and Ross B. D. (1994) Oxidative stress in the central nervous system: monitoring the metabolic response using the pentose phosphate pathway. Dev. Neurosci. 16, 328-336.
36. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
37. Quon D., Wang Y., Catalano R., Scardina J. M., Murakami K., and Cordell B. (1991) Formation of beta-amyloid protein deposits in brains of transgenic mice. Nature 352, 239-241.
38. Salahudeen A. K., Clark E. C., and Nath K. A. (1991) Hydrogen peroxide-induced renal injury. A protective role for pyruvate. J. Clin. Invest. 88, 1886-1893.
39. Schraufstatter I. U., Hinshaw D. B., Hyslop P. A., Spragg R. G., and Cochrane C. G. (1985) Glutathione cycle activity and pyridine nucleotide levels in oxidant-induced injury of cells. J. Clin. Invest. 76, 1131-1139.
40. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., and Kimura H. (1995) Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA 92, 1989-1993.
41. Selkoe D. J. (1994) Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10, 373-403.
42. Shearman M. S., Ragan C. I., and Iversen L. L. (1994) Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA 91, 1470-1474.
43. Simmons M. A. and Schneider C. R. (1993) Amyloid beta peptides act directly on single neurons. Neurosci. Lett. 150, 133-136.
44. Simmons L. K., May P. C., Tomaselli K. J., Rydel R. E., Fuson K. S., Brigham E. F., Wright S., Lieberburg I., Becker G. W., Brems D. N., Lieberburg I. R., and Li W. (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45, 373-379.
45. van Gool W. A., Kuiper M. A., Walstra G. J. M., Wolters E. C., and Bolhuis P. A. (1995) Concentration of Aβ in CSF. Ann. Neurol. 37, 277-279.
46. Varma S. and Devamanoharan P. S. (1990) Excretion of hydrogen peroxide in human urine. Free Radic. Res. Commun. 8, 73-78.
47. Varma S. D. and Devamanoharan P. S. (1995) Oxidative denaturation of lens protein: prevention by pyruvate. Ophthalmic Res. 27, 18-22.
48. Whitesell R. R., Ward M., McCall A. L., Granner D. K., and May J. M. (1995) Coupled glucose transport and metabolism in cultured neuronal cells: determination of the rate limiting step. J. Cereb. Blood Flow Metab. 15, 814-826.
49. Zhang Z., Drzewiecki G. J., Horn J. T., May P. C., and Hyslop P. A. (1994) Human cortical neuronal (HCN) cell lines: a model for amyloid β neurotoxicity. Neurosci. Lett. 177, 162-164.